Lars Øivind Høiseth

Dr. Lars Øivind Høiseth


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2012 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
LHLars Øivind Høiseth
Lars Øivind Høiseth
IHI. E. Hoff
I. E. Hoff
KMK. Myre
K. Myre
SLS. A. Landsverk
S. A. Landsverk
KKK. A. Kirkebøen
K. A. Kirkebøen

26 September 2011 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
LHLars Øivind Høiseth
Lars Øivind Høiseth
IHI. E. Hoff
I. E. Hoff
ØSØivind Skare
Øivind Skare
KKK. A. Kirkebøen
K. A. Kirkebøen
SLS. A. Landsverk
S. A. Landsverk

1 May 2021 in Journal of Vascular Surgery
Verified
Journal Article
Open access
HHHenrik Hoel
Henrik Hoel
EPErik Mulder Pettersen
Erik Mulder Pettersen
LHLars Øivind Høiseth
Lars Øivind Høiseth
IMIacob Mathiesen
Iacob Mathiesen
ASArne Seternes
Arne Seternes
JHJonny Hisdal
Jonny Hisdal
We investigated the effects of lower extremity intermittent negative pressure (INP) treatment for 1 hour two times daily for 12 weeks on the walking distance of patients with intermittent claudication (IC). Patients with IC were randomized to treatment with -40 mm Hg INP (treatment group) or -10 mm Hg INP (sham control group). Pain-free walking distance (PWD) and maximal walking distance (MWD) on a treadmill, resting and postexercise ankle-brachial index, resting and postischemic blood flow (plethysmography), and quality of life (EQ-5D-5L and Vascuqol-6) were measured at baseline and after 12 weeks of treatment. A total of 72 patients were randomized, and 63 had data available for the intention-to-treat analyses. The between-group comparisons showed a significant change in the PWD, favoring the treatment group over the sham control group (estimated treatment effect, 50 m; 95% confidence interval [CI], 11-89; P = .014). The PWD had increased by 68 m (P < .001) in the treatment group and 18 m (P = .064) in the sham control group. No significant difference was found in the change in the MWD between the two groups (estimated treatment effect, 42 m; 95% CI, -14 to 97; P = .139). The MWD had increased by 62 m (P = .006) in the treatment group and 20 m (P = .265) in the sham control group. For patients with a baseline PWD of <200 m (n = 56), significant changes had occurred in both PWD and MWD between the two groups, favoring the treatment group (estimated treatment effect, 42 m; 95% CI, 2-83; P = .042; and estimated treatment effect, 62 m; 95% CI, 5-118; P = .032; respectively). Both overall and for the group of patients with a PWD <200 m, no significant differences were found in the changes in the resting and postexercise ankle-brachial index, resting and postischemic blood flow, or quality of life parameters between the two groups. Treatment with -40 mm Hg INP increased the PWD compared with sham treatment in patients with IC. For the patients with a baseline PWD of <200 m, an increase was found in both PWD and MWD compared with sham treatment.

29 April 2014 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
LHLars Øivind Høiseth
Lars Øivind Høiseth
IHI E Hoff
I E Hoff
OHO A Hagen
O A Hagen
SLS A Landsverk
S A Landsverk
KKK A Kirkebøen
K A Kirkebøen

1 August 2021 in Annals of Vascular Surgery
Verified
Journal Article
Open access
HHHenrik Hoel
Henrik Hoel
EPErik Mulder Pettersen
Erik Mulder Pettersen
LHLars Øivind Høiseth
Lars Øivind Høiseth
IMIacob Mathiesen
Iacob Mathiesen
ASArne Seternes
Arne Seternes
JHJonny Hisdal
Jonny Hisdal
Background: Treatment with lower extremity intermittent negative pressure (INP) of-40 mm Hg for one hour twice daily for 12 weeks, increases walking capacity in patients with intermittent claudication (IC). However, the effects of INP treatment beyond 12 weeks have not been elucidated. The aim of the present study was to investigate the clinical effects of INP treatment after 24 weeks in patients with IC. Methods: This was a follow-up study after a randomized sham-controlled trial, where patients randomized to the active treatment group were offered to continue treatment for 12 additional weeks (24 weeks in total). Treatment with-40 mm Hg INP was applied in a pressure chamber sealed around the lower leg, and the patients were instructed to treat themselves at home one hour in the morning and one hour in the evening. Pain free walking distance (PWD), maximal walking distance (MWD), resting ankle-brachial index (ABI) and post exercise ABI were measured at baseline, after 12 and 24 weeks. Results: Ten out of 32 patients (31%) from the active treatment group in the initial trial were included in this follow-up study. At baseline, PWD was (mean +/- SD) 151 +/- 91 m and MWD was 362 +/- 159 m. There was a significant increase in both PWD and MWD after 24 weeks of treatment, compared to baseline (ANOVA; P = 0.006 and P = 0.012, respectively). Post hoc tests revealed that PWD increased significantly from baseline to 12 weeks (mean 81 m; 95% CI [6, 156]; P = 0.032), and that MWD increased significantly from 12 to 24 weeks (mean 145 m; 95% CI [22, 268]; P = 0.018). There were no significant changes in resting ABI or post exercise ABI during the 24-week treatment period (ANOVA; P = 0.157 and P = 0.450, respectively). Conclusion: Both PWD and MWD improved after treatment with - 40 mm Hg INP for one hour twice daily for 24 weeks, compared to baseline. The main improvement in PWD occurred during the first 12 weeks of treatment, whereas the main improvement in MWD occurred between 12 and 24 weeks of treatment.

9 December 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NSNiels A. Stens
Niels A. Stens
JHJonny Hisdal
Jonny Hisdal
EBEspen F. Bakke
Espen F. Bakke
NKNarinder Kaur
Narinder Kaur
ASArchana Sharma
Archana Sharma
LHLars Øivind Høiseth
Lars Øivind Høiseth
Whilst both cardiac output (CO) and total peripheral resistance (TPR) determine mean arterial blood pressure (MAP), their relative importance in the pressor response to isometric exercise remains unclear. This study aimed to elucidate the relative importance of these two different factors by examining pressor responses during cardiopulmonary unloading leading to step-wise reductions in CO. Hemodynamics were investigated in 11 healthy individuals before, during and after two-minute isometric exercise during lower body negative pressure (LBNP; -20mmHg and -40mmHg). The blood pressure response to isometric exercise was similar during normal and reduced preload, despite a step-wise reduction in CO during LBNP (-20mmHg and -40mmHg). During -20mmHg LBNP, the decreased stroke volume, and consequently CO, was counteracted by an increased TPR, while heart rate (HR) was unaffected. HR was increased during -40 mmHg LBNP, although insufficient to maintain CO; the drop in CO was perfectly compensated by an increased TPR to maintain MAP. Likewise, transient application of LBNP (-20mmHg and -40mmHg) resulted in a short transient drop in MAP, caused by a decrease in CO, which was compensated by an increase in TPR. This study suggests that, in case of reductions of CO, changes in TPR are primarily responsible for maintaining the pressor response during isometric exercise. This highlights the relative importance of TPR compared to CO in mediating the pressor response during isometric exercise.